These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3841625)

  • 1. Kinetic differences of the calcium-binding protein in absorptive hypercalciuric renal stone formers.
    Pinto B; Vilanova MA; Ruiz-Marcellan FJ
    Urol Res; 1985; 13(6):277-80. PubMed ID: 3841625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones.
    Vezzoli G; Macrina L; Rubinacci A; Spotti D; Arcidiacono T
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1450-1455. PubMed ID: 27284011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological studies in hypercalciuric and normocalciuric stone formers.
    Minisola S; Scarda A; Medori C; Valtorta C; Antonelli R; Tabolli S; Rossi W; Mazzuoli G
    Urol Int; 1985; 40(2):65-71. PubMed ID: 3992738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible link between vitamin D and hyperoxaluria in patients with renal stone disease.
    Giannini S; Nobile M; Castrignano R; Pati T; Tasca A; Villi G; Pellegrini F; D'Angelo A
    Clin Sci (Lond); 1993 Jan; 84(1):51-4. PubMed ID: 8382134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B; Lippuner K; Takkinen R; Villiger L; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1995; 10(9):1614-9. PubMed ID: 8559479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.
    Marangella M; Fruttero B; Bruno M; Linari F
    Clin Sci (Lond); 1982 Oct; 63(4):381-5. PubMed ID: 7105633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D; Ravery V; Boccon-Gibod L; Friedlander G
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
    Thode J; Finnerup B; Parvin C; Holmegaard SN; Skaarup P; Sørensen OH; Transbøl I
    Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships between circulating vitamin D metabolites in normocalciuric and hypercalciuric renal stone formers.
    Gascon-Barré M; D'Amour P; Dufresne L; Perreault JP
    Ann Nutr Metab; 1985; 29(5):289-96. PubMed ID: 3876804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low calcium diet in hypercalciuric calcium nephrolithiasis: first do no harm.
    Hess B
    Scanning Microsc; 1996; 10(2):547-54; discussion 554-6. PubMed ID: 9813631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate metabolism and renal calcium stone disease.
    Wikström B
    Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak.
    Rendina D; Mossetti G; De Filippo G; Cioffi M; Strazzullo P
    J Clin Endocrinol Metab; 2006 Mar; 91(3):959-63. PubMed ID: 16352682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between 1.25 dihydroxyvitamin D serum levels and fractional rate of intestinal calcium absorption in hypercalciuric nephrolithiasis. Role of phosphate.
    Alvarez-Arroyo MV; Traba ML; Rapado A; de la Piedra C; Torralbo M
    Urol Res; 1992; 20(1):96-7. PubMed ID: 1736497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence for a glucose-dependent renal phosphorus leak in normo- and hypercalciuric stone-formers (author's transl)].
    Aubert J; Ulmann A; Lacour B; Bader C; Funck-Brentano JL
    Nephrologie; 1980; 1(4):159-62. PubMed ID: 6895406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial forms of hypercalciuria.
    Favus MJ
    J Urol; 1989 Mar; 141(3 Pt 2):719-22. PubMed ID: 2645430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium metabolism in renal stone disease.
    Johansson G; Backman U; Danielson BG; Ljunghall S; Wikström B
    Invest Urol; 1980 Sep; 18(2):93-6. PubMed ID: 7410037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered kinetics of an intravenous calcium load in idiopathic hypercalciuria.
    Nunziata V; Giannattasio R; di Giovanni G; Corrado MF; Galletti F; Mancini M
    Metabolism; 1989 Sep; 38(9):826-30. PubMed ID: 2770533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers.
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Am J Nephrol; 1985; 5(1):40-4. PubMed ID: 3970077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.